Rhumbline Advisers Icu Medical Inc Transaction History

Rhumbline Advisers

  • $109 Billion
  • Q4 2024

A detailed history of Rhumbline Advisers transactions in Icu Medical Inc stock. As of the latest transaction made, Rhumbline Advisers holds 67,891 shares of ICUI stock, worth $11.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
67,891
Previous 71,178 4.62%
Holding current value
$11.3 Million
Previous $13 Million 18.76%
% of portfolio
0.01%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 30, 2025
SELL
$153.2 - $183.79 $503,568 - $604,117
-3,287 Reduced 4.62%
67,891 $10.5 Million
Q3 2024

Nov 12, 2024
BUY
$114.88 - $182.17 $489,618 - $776,408
4,262 Added 6.37%
71,178 $13 Million
Q2 2024

Aug 01, 2024
BUY
$94.53 - $120.55 $1.18 Million - $1.51 Million
12,519 Added 23.01%
66,916 $7.95 Million
Q1 2024

May 09, 2024
SELL
$86.88 - $112.48 $669,931 - $867,333
-7,711 Reduced 12.42%
54,397 $5.84 Million
Q4 2023

Feb 08, 2024
SELL
$81.08 - $119.29 $12,486 - $18,370
-154 Reduced 0.25%
62,108 $6.19 Million
Q3 2023

Nov 09, 2023
SELL
$115.27 - $182.23 $55,675 - $88,017
-483 Reduced 0.77%
62,262 $7.41 Million
Q2 2023

Aug 08, 2023
SELL
$161.03 - $209.15 $365,538 - $474,770
-2,270 Reduced 3.49%
62,745 $11.2 Million
Q1 2023

May 11, 2023
SELL
$153.15 - $198.21 $66,313 - $85,824
-433 Reduced 0.66%
65,015 $10.7 Million
Q4 2022

Feb 14, 2023
BUY
$136.25 - $165.56 $614,078 - $746,178
4,507 Added 7.4%
65,448 $10.3 Million
Q3 2022

Nov 10, 2022
BUY
$149.44 - $188.1 $273,325 - $344,034
1,829 Added 3.09%
60,941 $9.18 Million
Q2 2022

Aug 11, 2022
BUY
$161.4 - $229.7 $961,459 - $1.37 Million
5,957 Added 11.21%
59,112 $9.72 Million
Q1 2022

May 12, 2022
SELL
$203.51 - $247.46 $275,145 - $334,565
-1,352 Reduced 2.48%
53,155 $11.8 Million
Q4 2021

Feb 10, 2022
BUY
$220.96 - $247.44 $263,384 - $294,948
1,192 Added 2.24%
54,507 $12.9 Million
Q3 2021

Nov 12, 2021
SELL
$186.8 - $260.0 $271,046 - $377,260
-1,451 Reduced 2.65%
53,315 $12.4 Million
Q2 2021

Aug 05, 2021
SELL
$190.83 - $215.73 $141,023 - $159,424
-739 Reduced 1.33%
54,766 $11.3 Million
Q1 2021

May 06, 2021
SELL
$197.58 - $222.54 $108,273 - $121,951
-548 Reduced 0.98%
55,505 $11.4 Million
Q4 2020

Feb 10, 2021
BUY
$177.6 - $214.65 $27,350 - $33,056
154 Added 0.28%
56,053 $12 Million
Q3 2020

Nov 12, 2020
SELL
$177.7 - $200.24 $236,518 - $266,519
-1,331 Reduced 2.33%
55,899 $10.2 Million
Q2 2020

Aug 13, 2020
BUY
$172.31 - $230.89 $278,452 - $373,118
1,616 Added 2.91%
57,230 $10.5 Million
Q1 2020

May 06, 2020
BUY
$160.04 - $216.15 $453,233 - $612,136
2,832 Added 5.37%
55,614 $11.2 Million
Q4 2019

Feb 05, 2020
SELL
$151.88 - $189.51 $83,230 - $103,851
-548 Reduced 1.03%
52,782 $9.88 Million
Q3 2019

Oct 23, 2019
BUY
$154.21 - $257.38 $581,525 - $970,579
3,771 Added 7.61%
53,330 $8.51 Million
Q2 2019

Aug 14, 2019
BUY
$212.8 - $251.91 $778,422 - $921,486
3,658 Added 7.97%
49,559 $12.5 Million
Q1 2019

May 01, 2019
BUY
$221.09 - $253.28 $127,126 - $145,636
575 Added 1.27%
45,901 $11 Million
Q4 2018

Jan 31, 2019
BUY
$213.13 - $281.01 $2.61 Million - $3.45 Million
12,261 Added 37.08%
45,326 $10.4 Million
Q3 2018

Nov 07, 2018
BUY
$265.5 - $307.63 $43,542 - $50,451
164 Added 0.5%
33,065 $9.35 Million
Q2 2018

Aug 06, 2018
BUY
$245.65 - $309.75 $415,639 - $524,097
1,692 Added 5.42%
32,901 $9.66 Million
Q1 2018

May 02, 2018
SELL
$213.2 - $261.85 $1.06 Million - $1.3 Million
-4,959 Reduced 13.71%
31,209 $7.88 Million
Q4 2017

Feb 09, 2018
BUY
$186.1 - $220.45 $937,385 - $1.11 Million
5,037 Added 16.18%
36,168 $7.81 Million
Q3 2017

Nov 06, 2017
BUY
$164.9 - $187.15 $5.13 Million - $5.83 Million
31,131
31,131 $5.79 Million

Others Institutions Holding ICUI

# of Institutions
303
Shares Held
24M
Call Options Held
51K
Put Options Held
54.8K
View Full List

About ICU MEDICAL INC

ICUI Quotes by TradingView
  • Ticker ICUI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 23,899,400
  • Market Cap $3.97B
  • Description
  • ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap and Swa...
More about ICUI
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email